Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Sanofi
Condition: Prostatic Neoplasms
NCT01576029
Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.